MRSA/MSSA Blood Culture Test

MicroPhage's MRSA/MSSA blood culture test enables clinicians to direct the most appropriate therapy by identifying and determining methicillin resistance or susceptibility of S. aureus directly from blood cultures in five hours or less – two or more days faster than standard AST testing.

Current diagnostic methods require 48 to 72 hours – more time than is clinically permissible – meaning physicians often base treatments on their experience rather than individual patient data. Despite the medical community's best efforts, fatality rates are increasing largely due to antibiotic resistance.

MicroPhage's bacteriophage amplification platform enables rapid identification of S. aureus and determination of methicillin resistance (MRSA) or methicillin susceptibility (MSSA) to deliver results the laboratory and clinicians need, when they need them. Simple to perform, without the need for expensive equipment, MicroPhage is making diagnostics accessible to institutions, large and small.

Reduce unnecessary therapy – Prescribe the most-appropriate treatment by getting critical antibiotic susceptibility and resistance information.
Simplify testing with a phenotypic test – Rely on viable bacteria for results that are directly related to the sample – no primers or molecular markers.
Benefit from an easy-to-use platform – Go direct from a blood culture – without the need for expensive equipment, batching, specialized personnel, or sample preparation.
Get definitive results faster than standard diagnostic methods – Receive culture-quality results in approximately five hours.
Improve outcomes – Enable patient care, reduce costs, and save lives.

High-value diagnostic, easy-to-use platform
The MicroPhage MRSA/MSSA Blood Culture Test delivers rapid results that directly impact patient care. The test itself is simple to perform and does not require expensive equipment, making this critical diagnostic available to all institutions – large and small.

Identification and susceptibility/ resistance information
Direct from blood culture – with three minutes of hands-on time
Unbatched test format
Visual interpretation
Results available in approximately five hours
Specificity in the high 90s
Sensitivity in the low to mid 90s

Learn more about the Investigational Use Only program for the MicroPhage MSRA/MSSA Blood Culture Test. A MicroPhage-sponsored program, the IUO program was designed to let you:

Try the product in your lab, prior to commercial availability
Have a small study sponsored by MicroPhage with publication rights
Work with MicroPhage to help improve the product or expand intended indications for use in your lab

1 Pfaller et al. J. Antimicrob. Agent. Chemother. (42): 1762-1770.
This test is not cleared by the FDA and not yet available for sale in the U.S. market. This test is CE marked for sale outside the U.S.